ReP USP - Resultado da busca

Artigo de periodico
Development and cytotoxicity evaluation of multiple nanoemulsions for oral co-delivery of 5-fluorouracil and short chain triglycerides for colorectal cancer (2023)
Fukumori, Claudio ; Branco, Paola Cristina ; Barreto, Thayná ; Ishida, Kelly ; Lopes, Luciana Biagini
Source: European Journal of Pharmaceutical Sciences. Unidade: ICB
Subjects: FARMACOLOGIA, MICROBIOLOGIA, NEOPLASIAS COLORRETAIS, ANTINEOPLÁSICOS, QUIMIOTERAPIA, CITOTOXINAS, GORDURAS, ALGINATOS, MUTAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FUKUMORI, Claudio et al. Development and cytotoxicity evaluation of multiple nanoemulsions for oral co-delivery of 5-fluorouracil and short chain triglycerides for colorectal cancer. European Journal of Pharmaceutical Sciences, v. 187, p. 1-15, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2023.106465. Acesso em: 14 nov. 2024.
APA
Fukumori, C., Branco, P. C., Barreto, T., Ishida, K., & Lopes, L. B. (2023). Development and cytotoxicity evaluation of multiple nanoemulsions for oral co-delivery of 5-fluorouracil and short chain triglycerides for colorectal cancer. European Journal of Pharmaceutical Sciences, 187, 1-15. doi:10.1016/j.ejps.2023.106465
NLM
Fukumori C, Branco PC, Barreto T, Ishida K, Lopes LB. Development and cytotoxicity evaluation of multiple nanoemulsions for oral co-delivery of 5-fluorouracil and short chain triglycerides for colorectal cancer [Internet]. European Journal of Pharmaceutical Sciences. 2023 ; 187 1-15.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.ejps.2023.106465
Vancouver
Fukumori C, Branco PC, Barreto T, Ishida K, Lopes LB. Development and cytotoxicity evaluation of multiple nanoemulsions for oral co-delivery of 5-fluorouracil and short chain triglycerides for colorectal cancer [Internet]. European Journal of Pharmaceutical Sciences. 2023 ; 187 1-15.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.ejps.2023.106465
Artigo de periodico
Hyaluronic acid nanoemulsions improve piplartine cytotoxicity in 2D and 3D breast cancer models and reduce tumor development after intraductal administration (2022)
Dartora, Vanessa Franco Carvalho ; Salata, Giovanna Cassone ; Passos, Julia Sapienza ; Branco, Paola Cristina ; Silveira, Edilberto ; Steiner, Alexandre Alarcon ; Costa-Lotufo, Letícia Veras ; Lopes, Luciana Biagini
Source: International Journal of Biological Macromolecules. Unidade: ICB
Subjects: IMUNOLOGIA, FARMACOLOGIA, NEOPLASIAS MAMÁRIAS, ALCALOIDES, PRODUTOS NATURAIS, ÓLEOS ESSENCIAIS, CÉLULAS CULTIVADAS DE TUMOR, BIOPOLÍMEROS, CITOTOXINAS, NANOPARTÍCULAS, QUITOSANA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DARTORA, Vanessa Franco Carvalho et al. Hyaluronic acid nanoemulsions improve piplartine cytotoxicity in 2D and 3D breast cancer models and reduce tumor development after intraductal administration. International Journal of Biological Macromolecules, v. 219, p. 84-95, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.ijbiomac.2022.07.162. Acesso em: 14 nov. 2024.
APA
Dartora, V. F. C., Salata, G. C., Passos, J. S., Branco, P. C., Silveira, E., Steiner, A. A., et al. (2022). Hyaluronic acid nanoemulsions improve piplartine cytotoxicity in 2D and 3D breast cancer models and reduce tumor development after intraductal administration. International Journal of Biological Macromolecules, 219, 84-95. doi:10.1016/j.ijbiomac.2022.07.162
NLM
Dartora VFC, Salata GC, Passos JS, Branco PC, Silveira E, Steiner AA, Costa-Lotufo LV, Lopes LB. Hyaluronic acid nanoemulsions improve piplartine cytotoxicity in 2D and 3D breast cancer models and reduce tumor development after intraductal administration [Internet]. International Journal of Biological Macromolecules. 2022 ; 219 84-95.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.ijbiomac.2022.07.162
Vancouver
Dartora VFC, Salata GC, Passos JS, Branco PC, Silveira E, Steiner AA, Costa-Lotufo LV, Lopes LB. Hyaluronic acid nanoemulsions improve piplartine cytotoxicity in 2D and 3D breast cancer models and reduce tumor development after intraductal administration [Internet]. International Journal of Biological Macromolecules. 2022 ; 219 84-95.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.ijbiomac.2022.07.162
Artigo de periodico
A lipid-based in situ-forming hexagonal phase for prolonged retention and drug release in the breast tissue (2022)
Salata, Giovanna Cassone ; Malagó, Isabella Draszesski ; Lopes, Luciana Biagini
Source: AAPS PharmSciTech. Unidade: ICB
Subjects: FARMACOLOGIA, NEOPLASIAS MAMÁRIAS, LIPÍDEOS, CORANTES FLUORESCENTES, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SALATA, Giovanna Cassone e MALAGÓ, Isabella Draszesski e LOPES, Luciana Biagini. A lipid-based in situ-forming hexagonal phase for prolonged retention and drug release in the breast tissue. AAPS PharmSciTech, v. 23, p. 1-14, 2022Tradução . . Disponível em: https://doi.org/10.1208/s12249-022-02411-9. Acesso em: 14 nov. 2024.
APA
Salata, G. C., Malagó, I. D., & Lopes, L. B. (2022). A lipid-based in situ-forming hexagonal phase for prolonged retention and drug release in the breast tissue. AAPS PharmSciTech, 23, 1-14. doi:10.1208/s12249-022-02411-9
NLM
Salata GC, Malagó ID, Lopes LB. A lipid-based in situ-forming hexagonal phase for prolonged retention and drug release in the breast tissue [Internet]. AAPS PharmSciTech. 2022 ; 23 1-14.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1208/s12249-022-02411-9
Vancouver
Salata GC, Malagó ID, Lopes LB. A lipid-based in situ-forming hexagonal phase for prolonged retention and drug release in the breast tissue [Internet]. AAPS PharmSciTech. 2022 ; 23 1-14.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1208/s12249-022-02411-9
Artigo de periodico
Rethinking breast cancer chemoprevention: technological advantages and enhanced performance of a Nanoethosomal-Based Hydrogel for topical administration of Fenretinide (2022)
Apolinário, Alexsandra Conceição ; Salata, Giovanna Cassone ; Souza, Marcelo Medina de; Chorilli, Marlus ; Lopes, Luciana Biagini
Source: AAPS PharmSciTech. Unidade: ICB
Subjects: FARMACOLOGIA, GEL (FORMAS FARMACÊUTICAS), MEDICAMENTO, NANOTECNOLOGIA, QUIMIOTERÁPICOS, ANTINEOPLÁSICOS, NEOPLASIAS MAMÁRIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
APOLINÁRIO, Alexsandra Conceição et al. Rethinking breast cancer chemoprevention: technological advantages and enhanced performance of a Nanoethosomal-Based Hydrogel for topical administration of Fenretinide. AAPS PharmSciTech, v. 23, p. 1-14, 2022Tradução . . Disponível em: https://doi.org/10.1208/s12249-022-02257-1. Acesso em: 14 nov. 2024.
APA
Apolinário, A. C., Salata, G. C., Souza, M. M. de, Chorilli, M., & Lopes, L. B. (2022). Rethinking breast cancer chemoprevention: technological advantages and enhanced performance of a Nanoethosomal-Based Hydrogel for topical administration of Fenretinide. AAPS PharmSciTech, 23, 1-14. doi:10.1208/s12249-022-02257-1
NLM
Apolinário AC, Salata GC, Souza MM de, Chorilli M, Lopes LB. Rethinking breast cancer chemoprevention: technological advantages and enhanced performance of a Nanoethosomal-Based Hydrogel for topical administration of Fenretinide [Internet]. AAPS PharmSciTech. 2022 ; 23 1-14.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1208/s12249-022-02257-1
Vancouver
Apolinário AC, Salata GC, Souza MM de, Chorilli M, Lopes LB. Rethinking breast cancer chemoprevention: technological advantages and enhanced performance of a Nanoethosomal-Based Hydrogel for topical administration of Fenretinide [Internet]. AAPS PharmSciTech. 2022 ; 23 1-14.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1208/s12249-022-02257-1
Artigo de periodico
Phosphatidylcholine-based nanoemulsions for paclitaxel and a P-Glycoprotein inhibitor delivery and breast cancer intraductal treatment (2022)
Salata, Giovanna Cassone ; Lopes, Luciana Biagini
Source: Pharmaceuticals. Unidade: ICB
Subjects: FARMACOLOGIA, GLICOPROTEÍNAS DA MEMBRANA, NEOPLASIAS MAMÁRIAS, ANTINEOPLÁSICOS, MAMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SALATA, Giovanna Cassone e LOPES, Luciana Biagini. Phosphatidylcholine-based nanoemulsions for paclitaxel and a P-Glycoprotein inhibitor delivery and breast cancer intraductal treatment. Pharmaceuticals, v. 15, n. 9, p. 1-23, 2022Tradução . . Disponível em: https://doi.org/10.3390/ph15091110. Acesso em: 14 nov. 2024.
APA
Salata, G. C., & Lopes, L. B. (2022). Phosphatidylcholine-based nanoemulsions for paclitaxel and a P-Glycoprotein inhibitor delivery and breast cancer intraductal treatment. Pharmaceuticals, 15( 9), 1-23. doi:10.3390/ph15091110
NLM
Salata GC, Lopes LB. Phosphatidylcholine-based nanoemulsions for paclitaxel and a P-Glycoprotein inhibitor delivery and breast cancer intraductal treatment [Internet]. Pharmaceuticals. 2022 ; 15( 9): 1-23.[citado 2024 nov. 14 ] Available from: https://doi.org/10.3390/ph15091110
Vancouver
Salata GC, Lopes LB. Phosphatidylcholine-based nanoemulsions for paclitaxel and a P-Glycoprotein inhibitor delivery and breast cancer intraductal treatment [Internet]. Pharmaceuticals. 2022 ; 15( 9): 1-23.[citado 2024 nov. 14 ] Available from: https://doi.org/10.3390/ph15091110
Artigo de periodico
Optimization of nanoemulsified systems containing lamellar phases for co-delivery of celecoxib and endoxifen to the skin aiming for breast cancer chemoprevention and treatment (2022)
Mojeiko, Gabriela; Apolinário, Alexsandra Conceição ; Salata, Giovanna Cassone ; Chorilli, Marlus ; Lopes, Luciana Biagini
Source: Colloids and Surfaces A: Physicochemical and Engineering Aspects. Unidade: ICB
Subjects: FARMACOLOGIA, ÁCIDOS GRAXOS, ÓLEOS VEGETAIS, NEOPLASIAS MAMÁRIAS, METABÓLITOS, QUIMIOTERÁPICOS, CÉLULAS CULTIVADAS DE TUMOR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOJEIKO, Gabriela et al. Optimization of nanoemulsified systems containing lamellar phases for co-delivery of celecoxib and endoxifen to the skin aiming for breast cancer chemoprevention and treatment. Colloids and Surfaces A: Physicochemical and Engineering Aspects, v. 646, p. 1-14, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.colsurfa.2022.128901. Acesso em: 14 nov. 2024.
APA
Mojeiko, G., Apolinário, A. C., Salata, G. C., Chorilli, M., & Lopes, L. B. (2022). Optimization of nanoemulsified systems containing lamellar phases for co-delivery of celecoxib and endoxifen to the skin aiming for breast cancer chemoprevention and treatment. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 646, 1-14. doi:10.1016/j.colsurfa.2022.128901
NLM
Mojeiko G, Apolinário AC, Salata GC, Chorilli M, Lopes LB. Optimization of nanoemulsified systems containing lamellar phases for co-delivery of celecoxib and endoxifen to the skin aiming for breast cancer chemoprevention and treatment [Internet]. Colloids and Surfaces A: Physicochemical and Engineering Aspects. 2022 ; 646 1-14.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.colsurfa.2022.128901
Vancouver
Mojeiko G, Apolinário AC, Salata GC, Chorilli M, Lopes LB. Optimization of nanoemulsified systems containing lamellar phases for co-delivery of celecoxib and endoxifen to the skin aiming for breast cancer chemoprevention and treatment [Internet]. Colloids and Surfaces A: Physicochemical and Engineering Aspects. 2022 ; 646 1-14.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.colsurfa.2022.128901

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects